Latin America Hairy Cell Leukemia Treatment Market Size & Outlook
The hairy cell leukemia treatment market in Latin America is expected to reach a projected revenue of US$ 5.1 million by 2030. A compound annual growth rate of 4.3% is expected of Latin America hairy cell leukemia treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$3.8
Forecast, 2030 (US$M)
$5.1
CAGR, 2024 - 2030
4.3%
Report Coverage
Latin America
Latin America hairy cell leukemia treatment market highlights
- The Latin America hairy cell leukemia treatment market generated a revenue of USD 3.8 million in 2023.
- The market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, chemotherapy was the largest revenue generating treatment in 2023.
- Chemotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2023 | USD 3.8 million |
| Market revenue in 2030 | USD 5.1 million |
| Growth rate | 4.3% (CAGR from 2024 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy |
| Key market players worldwide | Pfizer Inc, Roche Holding AG, Janssen Pharmaceuticals, Emcure Pharmaceuticals, Dr Reddy's Laboratories Ltd ADR, Amgen Inc, Hospira, AbbVie Inc, AstraZeneca PLC |
Other key industry trends
- In terms of revenue, Latin America region accounted for 3.8% of the global hairy cell leukemia treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 36.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hairy Cell Leukemia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hospira | View profile | 10001+ | Lake Forest, Illinois, United States, North America | http://hospira.com |
| Emcure Pharmaceuticals | View profile | 10001+ | Pune, Maharashtra, India, Asia | https://www.emcure.com/ |
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | https://www.drreddys.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
